Literature DB >> 23264134

Recalcitrant primary subcutaneous phaeohyphomycosis due to Phialophora verrucosa.

Lu-juan Gao1, Jin Yu, Duan-li Wang, Ruo-yu Li.   

Abstract

Phialophora verrucosa has rarely been reported for causing phaeohyphomycosis, which tends to occur in immunocompromised individuals. The case of primary subcutaneous phaeohyphomycosis due to P. verrucosa in an otherwise healthy Chinese female is presented. The girl presented with asymptomatic skin lesions when she was only 16 year old. Histological examinations revealed multiple dematiceous hyphael elements in the dermis and subcutaneous tissues. Fungal cultures were identified as P. verrucosa repeatedly based on the morphological features and confirmed by the internal transcribed spacer region nucleotide sequencing. The infection was so extremely recalcitrant that prolonged systemic antifungal regimens for 12 years revealed limited effect. The skin lesions slowly progressed and caused marked disfigurement despite the encouraging results of in vitro susceptibility. However, no relevant side effects have been reported in the course, and the patient gave birth to a healthy baby while under the maintenance treatment of itraconazole and terbinafine. This case is special in terms of the early onset, the rare clinical aspect of the pathogen, the discrepancy between in vitro and in vivo antifungal activities and especially the prolonged and recalcitrant course in such an otherwise healthy host.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264134     DOI: 10.1007/s11046-012-9602-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

Review 1.  Therapeutic approaches to subcutaneous mycoses.

Authors:  Tetsuya Koga; Tetsuo Matsuda; Tadahiko Matsumoto; Masutaka Furue
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

2.  The frequent isolation of Phialophora verrucosa and Phialophora pedrosoi from natural sources.

Authors:  E Gezuele; J E Mackinnon; I A Conti-Díaz
Journal:  Sabouraudia       Date:  1972-11

3.  Phialophora verrucosa infection in a BMT patient.

Authors:  T S Lundstrom; M R Fairfax; M C Dugan; J A Vazquez; P H Chandrasekar; E Abella; C Kasten-Sportes
Journal:  Bone Marrow Transplant       Date:  1997-11       Impact factor: 5.483

Review 4.  Treatment of chromoblastomycosis.

Authors:  L Tuffanelli; P B Milburn
Journal:  J Am Acad Dermatol       Date:  1990-10       Impact factor: 11.527

Review 5.  Case report. Phaeohyphomycosis caused by Phialophora verrucosa developed in a patient with non-HIV acquired immunodeficiency syndrome.

Authors:  S Ohira; K Isoda; H Hamanaka; K Takahashi; K Nishimoto; H Mizutani
Journal:  Mycoses       Date:  2002-02       Impact factor: 4.377

6.  Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.

Authors:  M R McGinnis
Journal:  J Am Acad Dermatol       Date:  1983-01       Impact factor: 11.527

7.  Subcutaneous cystic granuloma caused by Phialophora verrucosa.

Authors:  T Iwatsu; M Miyaji
Journal:  Mycopathologia       Date:  1978-11-10       Impact factor: 2.574

8.  Phialophora verrucosa-induced subcutaneous phaeohyphomycosis. Fine needle aspiration findings.

Authors:  V J Schnadig; E G Long; J M Washington; M C McNeely; B A Troum
Journal:  Acta Cytol       Date:  1986 Jul-Aug       Impact factor: 2.319

9.  Phialophora verrucosa infection in an AIDS patient.

Authors:  J M Duggan; M D Wolf; C A Kauffman
Journal:  Mycoses       Date:  1995 May-Jun       Impact factor: 4.377

10.  Multifocal subcutaneous phaeohyphomycosis caused by Phialophora verrucosa.

Authors:  Masatomo Kimura; Akio Goto; Tomoko Furuta; Takao Satou; Shigeo Hashimoto; Kazuko Nishimura
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534

View more
  7 in total

1.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 2.  Black Molds and Melanized Yeasts Pathogenic to Humans.

Authors:  Anuradha Chowdhary; John Perfect; G Sybren de Hoog
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

3.  Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice.

Authors:  Weiwei Wu; Ruijun Zhang; Xiaowen Wang; Yinggai Song; Zhengyang Liu; Wenling Han; Ruoyu Li
Journal:  Mycopathologia       Date:  2016-07-15       Impact factor: 2.574

4.  1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa.

Authors:  Marcela Queiroz Granato; Diego de Souza Gonçalves; Sergio Henrique Seabra; Malachy McCann; Michael Devereux; André Luis Souza Dos Santos; Lucimar Ferreira Kneipp
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

5.  Chromoblastomycosis Caused by Phialophora-Proven Cases from Mexico.

Authors:  Sarah A Ahmed; Alexandro Bonifaz; Gloria M González; Leandro F Moreno; Nickolas Menezes da Silva; Vania A Vicente; Ruoyu Li; Sybren de Hoog
Journal:  J Fungi (Basel)       Date:  2021-01-29

Review 6.  Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

Authors:  Emilie Corvilain; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2018-08-22       Impact factor: 8.317

7.  Biodiversity and human-pathogenicity of Phialophora verrucosa and relatives in Chaetothyriales.

Authors:  Y Li; J Xiao; G S de Hoog; X Wang; Z Wan; J Yu; W Liu; R Li
Journal:  Persoonia       Date:  2016-08-02       Impact factor: 11.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.